(주)신영로파마

LAIS TABLETS 자료실

2023. 10. 02. 전체글: 41



21	24-Rossi Monasterolo, A pilot studyof feasibility of ultra-rush (20-25 minutes)	(주)신영	2019.08.28	11244

20	23-Safety of tolerability of ultra-rush (20 minutes) sublingual immunotherapyin patients with allerg	(주)신영	2019.08.28	11556

19	22-Agostinis Tellarini CanonicaFalagiani, Safety of sublingual immunotherapy with a monomeric allerg	(주)신영	2019.08.28	11306

18	21-Arena Barbatano Gammeri BrunoRiva, Specific immunotherapy of allergic diseases a three years pers	(주)신영	2019.08.28	10192

17	20-Rossi Monasterolo, Safety ofultra rush (two hours) sublingual swallow immunotherapy	(주)신영	2019.08.28	10867

16	19-Marogna Massolo, SublingualImmunotherapy in the contest of a clinical practice	(주)신영	2019.08.28	10961

15	18-Lombardi Gargioni Melchiorre,Safety of sublingual immunotherapy with monomeric allergoid in adult	(주)신영	2019.08.28	11106

14	15-marogna sublingual immunotherapyfor allergic respiratory disease	(주)신영	2019.08.28	10864

13	14-Marogna Bruno Massolo Falagiani,Long lasting effcts of sublingual immunotherapy or house dust mit	(주)신영	2019.08.28	10855

12	13-Ippoliti, Psycological stressaffects response to sublingual immunotherapy in asthmtic children	(주)신영	2019.08.28	11903